Skip to main content
TipRanks
Go Ultimate75% OFF

Moderna (MRNA) Operating Expense Breakdown

19,096 Followers

Operating Expense Breakdown

Moderna reported operating expenses of $867.00M in Q2 2026, up 5.5% from Q1 2026 and down 6.8% year over year. The highest value was $1.88B in Q4 2023.

Details core costs like R&D, marketing, and admin, offering insight into how efficiently Moderna runs and where it’s prioritizing investment, crucial for understanding its focus on innovation and market expansion.

$0.00$500.00M$1.00B$1.50BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Chart Insights

R&D and SG&A have been pared back sharply from their pandemic-era peaks as Moderna shifts from volume-driven spending to a leaner operating base—this reflects Phase III wind‑downs and explicit cost discipline. Management confirms lower adjusted cash costs and SG&A targets while keeping R&D weighted to H2, so investment is being deferred rather than cut entirely. That boosts adjusted profitability but raises execution risk for late‑stage programs and global commercialization; the large litigation settlement inflates GAAP losses but is distinct from the OpEx trend.

MRNA Operating Expense Breakdown

PeriodResearch and DevelopmentSelling, General, and AdministrativeTotal
Q2 2026Jun 30, 2026$651.00M$216.00M$867.00M
Q1 2026Mar 31, 2026$649.00M$173.00M$822.00M
Q4 2025Dec 31, 2025$775.00M$308.00M$1.08B
Q3 2025Sep 30, 2025$801.00M$268.00M$1.07B
Q2 2025Jun 30, 2025$700.00M$230.00M$930.00M
Q1 2025Mar 31, 2025$856.00M$212.00M$1.07B
Q4 2024Dec 31, 2024$1.12B$351.00M$1.47B
Q3 2024Sep 30, 2024$1.14B$281.00M$1.42B
Q2 2024Jun 30, 2024$1.22B$268.00M$1.49B
Q1 2024Mar 31, 2024$1.06B$274.00M$1.34B
Q4 2023Dec 31, 2023$1.41B$470.00M$1.88B
Q3 2023Sep 30, 2023$1.16B$442.00M$1.60B
Q2 2023Jun 30, 2023$1.15B$332.00M$1.48B
Q1 2023Mar 31, 2023$1.13B$305.00M$1.44B
Q4 2022Dec 31, 2022$1.21B$375.00M$1.59B
Q3 2022Sep 30, 2022$820.00M$278.00M$1.10B
Q2 2022Jun 30, 2022$710.00M$211.00M$921.00M
Q1 2022Mar 31, 2022$554.00M$268.00M$822.00M
Q4 2021Dec 31, 2021$648.00M$201.00M$849.00M
Q3 2021Sep 30, 2021$521.00M$168.00M$689.00M
Q2 2021Jun 30, 2021$421.00M$121.00M$542.00M
Q1 2021Mar 31, 2021$401.00M$77.00M$478.00M
Q4 2020Dec 31, 2020$758.85M$78.73M$837.58M
Q3 2020Sep 30, 2020$344.49M$48.54M$393.03M
Q2 2020Jun 30, 2020$152.00M$37.00M$189.00M
Q1 2020Mar 31, 2020$115.00M$24.00M$139.00M

Related KPIs